ELISA – News and Features

A new, non-invasive test for bladder cancer that examines urine proteins may be on the horizon.

Researchers have discovered a mechanism that helps explain the link between the protein PKMzeta and neurological disorders such as Alzheimer’s disease.

Research suggests that lonely people may think differently from others regardless of the size of their social networks.

Adding a peptide to a chemotherapy drug used to treat colorectal cancer avoids the side effects this treatment can have on normal cells, including potential chemotherapy resistance.

A team from Wayne State University has discovered a new technology that will quickly and easily detect active Mycobacterium tuberculosis (TB) infection antibodies.

A new study has shown that platinum-based chemotherapy drugs, used to treat some colorectal cancers, can accumulate in surrounding healthy cells and reduce the tumor's sensitivity to treatment.

In a first-of-its-kind study, EMBL researchers have shown how DNA methylation across the genome contributes to the precise regulation of gene expression

Diagnostic testing is key in many areas including healthcare and preventative medicine, food safety and environmental monitoring. In this article, we will consider what lateral flow tests (LFTs) are, how they work and their applications.

This article will review the latest applications of mass spectrometry-based techniques across the stages of biopharmaceutical development and testing.

To learn more about T-cell testing, the types of diseases it can help to diagnose and its value in clinical trials, we spoke to Phill Keefe, chief executive officer of PerkinElmer’s Oxford Immunotec division.